# ASIA CHOICES CHampix (Varenicline) Observational Investigation in the CEssation of Smoking

> **NCT00808015** · — · COMPLETED · sponsor: **Pfizer** · enrollment: 1373 (actual)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** varenicline

## Key facts

- **NCT ID:** NCT00808015
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 1373 (ACTUAL)
- **Last updated:** 2015-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00808015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00808015, "ASIA CHOICES CHampix (Varenicline) Observational Investigation in the CEssation of Smoking". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00808015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*